RCH logo

PIPER - Paediatric Infant Perinatal Emergency Retrieval

Konakion MM Paediatric – (Phytomenadione/Vitamin K)

  • (2 mg in 0.2 mL)

    VITAMIN K

    Fat-soluble vitamin, coagulation factor.

    Preparations

    Inj: 10 mg/1 mL and 2 mg/0.2 mL.

    Tablet: 10 mg.

    IV Preparation and Compatibilities

    Do not mix with infusion fluids.

    Dose

    Vitamin K prophylaxis (prevention of haemorrhagic disease of the newborn).

    IM:

    Preferred route.

    Give as a single dose on day 1 of life.

    Birth weight < 1.5kg 0.5 mg (0.05 mL)
    Birth weight ≥ 1.5kg 1 mg (0.1 mL)

    Oral:

    May be used as an alternative to IM, but must be given as a THREE-dose regimen. Use Konakion MM® for oral dosing.

    Three oral doses:

    At birth 2 mg (0.2 mL)
    At 3 to 5 days of life 2 mg (0.2 mL)
    At 4 weeks of life 2 mg (0.2 mL)

    Treatment of Vitamin K deficient haemorrhagic disease:

    IV:

    1 mg slowly. Urgent replacement of clotting factors may also be necessary.

    CAUTION:  Give IV doses slowly due to risk of anaphylaxis.   

Disclaimer:  This Drug information was designed for use by PIPER Neonatal. Whilst great care has been taken to check the information is accurate, it is possible that errors may have been missed. Furthermore, dosage schedules are continually being revised and new side effects recognised. For these reasons, the reader is strongly advised to consult the drug companies' printed information before administering any of the drugs recommended in this book.
Most drugs in this document are appropriate only for specialist use in hospitals.  A number of drugs should only be used in consultation with the appropriate Paediatric subspecialist. 

Note: The electronic version of this guideline is the version currently in use.  Any printed version cannot be assumed to be current. Printed copies of this document are valid for